Join NNECOS for a fabulous weekend getaway!

Physicians

i3 Health designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants/Associates

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Nurse Practitioners

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.

Nursing Continuing Professional Development

A maximum of 11.25 ANCC contact hours may be earned by learners who successfully complete this nursing continuing professional development activity.

Continuing Pharmacy Education

i3 Health has approved this knowledge-based activity for 11.25 ACPE CE hours. The Universal Activity Number for this activity is JA0008128-0000-26-015-L01-P. Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity and the evaluation by providing your NABP ID and DOB, which must be submitted within 60 days of completion.

Social Workers

As a Jointly Accredited Organization, i3 Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 11.25 general continuing education credits.

Acknowledgement of Commercial Support

No commercial support was received for this activity.

Target Audience

This activity is designed for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners and other APRNs, social workers, genetic counselors, and all members of the oncology care team across Northern New England.

Faculty

Listed alphabetically by last name.

• Diego Adrianzen-Herrera, MD — AML Tumor Board Faculty/Co-Chair
• Rev. Kris Bowen, M.Div., BCC — Staff Chaplain, Department of Spiritual Health, Dartmouth-Hitchcock Medical Center — Existential Distress Faculty
• Lydia Chevalier, PhD — Dana-Farber Cancer Institute — Fertility Preservation & Family Planning Faculty
• Katherine Daniels, M.Div — Finding Awe Faculty
• Lindsay Dow, MD — Serious Illness Communication / Goals of Care Faculty
• Emily Hallgren, PhD — UVM — Financial Toxicity of Cancer Therapy Faculty
• Christi Hayes, MD — Dartmouth (Transplant) — AML Tumor Board Faculty
• Gina Hoxie, MPH — Medicare/Medicaid & Financial Considerations Faculty
• Noah Kolb, MD — Chemotherapy-Induced Peripheral Neuropathy Faculty
• Karlyn Martin, MD — Thrombosis and Cancer Faculty
• Elizabeth McGrath, DNP, APRN, AGACNP-BC, AOCNP, ACHPN — Palliative Care Symposium Chair
• Michael Pearl, MD — Treatment & Management of Gynecologic Malignancies Faculty
• Elizabeth Rickerson, MD — Interventional Pain Faculty
• Rev. Katie P. Rimer, Ed.D, BCC — Existential Distress Faculty
• Sivan Rotenberg, PhD, MA — Navigating Conversations with Challenging Patients & Families Faculty
• Parth Shah, MD — Dartmouth — AML Tumor Board Faculty
• Julian Sprague, MD, PhD — AML Tumor Board Faculty/Co-Chair
• Jamyl Walker, NP — Serious Illness Communication / Goals of Care Faculty
• Eric Winer, MD — Dana-Farber Cancer Institute — Grunberg Memorial Keynote, Advances in Leukemia

Learning Objectives

At the conclusion of this activity, participants should be able to:

• Apply advances in scientific and translational research in the care of patients
• Evaluate tools and strategies to improve the timely and effective delivery of palliative care to patients with cancer
• Develop and implement strategies to address healthcare provider resilience
• Implement new practices or review existing ones to improve the quality of care delivered for patients with complicated care needs
• Describe strategies to address financial toxicity and improve care delivery for rural cancer patients and families
• Apply current evidence-based approaches to the treatment and management of gynecologic malignancies and chemotherapy-induced peripheral neuropathy

Faculty Disclosure Declaration

i3 Health endorses the standards of the ACCME, ANCC, and ACPE that require everyone in a position to control the content of a CME/NCPD/CPE activity to disclose all financial relationships with ineligible companies that are related to the content of the CME/NCPD/CPE activity. CME/NCPD/CPE activities must be balanced, independent of commercial bias, and promote improvements or quality in health care. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when an individual has an opportunity to affect CME/NCPD/CPE content about products or services of an ineligible company with which he/she has a financial relationship, which therefore may bias their opinions and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks, or other financial benefits.

i3 Health will identify, review, and mitigate all relevant financial relationships that speakers, authors, or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. i3 Health does not endorse any products or services.

Relevant financial relationships exist between the following individuals and ineligible companies:

The i3 Health planners and managers have nothing to disclose. The NNECOS planners and managers have nothing to disclose.

Faculty disclosures coming soon.

Requirements for Credit

To claim credit, you must sign in and out each day, and complete the Annual Meeting Evaluation within 2 weeks of the conclusion of the event (by Saturday, November 21 at latest).

Disclaimer

The information provided at this CME/NCPD activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Unapproved Use Disclosure

i3 Health requires CME/NCPD/CPE faculty (speakers) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved), as well as any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact NNECOS at info@nnecos.org or (603) 887-1948 prior to the live event.

Technical/Credit Queries

Technical queries about this activity should be directed to info@nnecos.org. Questions regarding activity credit should be directed to support@i3Health.com.

NNECOS intends to pursue continuing education credit for Radiation Therapists (RTT). This credit has not yet been applied for; details will be added once available.

NNECOS is also offering up to $50 reimbursement for CAT 2 Genetic Counseling Credit submission